EXPRESSION VECTOR BASED ON ADENO-ASSOCIATED VIRUS AND METHOD OF ITS USE FOR EMERGENCY PREVENTION AND PROPHYLAXIS OF DISEASES CAUSED BY SARS-CoV-2 VIRUS (VERSIONS) Russian patent published in 2022 - IPC C12N1/00 C12N15/62 C12N15/866 C12N7/00 A61K39/215 A61P31/14 

FIELD: biotechnology, immunology and microbiology.

SUBSTANCE: inventions group relates to biotechnology, immunology and microbiology. An expression vector based on a recombinant adeno-associated virus with an integrated genetic construct has been created that expresses a recombinant antibody having a CDR1 represented by the amino acid sequence SEQ ID NO:1, CDR2 represented by the amino acid sequence SEQ ID NO:2, CDR3 represented by the amino acid sequence SEQ ID NO: 3 or having a CDR1 represented by the amino acid sequence of SEQ ID NO:4, a CDR2 represented by the amino acid sequence of SEQ ID NO:5, CDR3 represented by the amino acid sequence of SEQ ID NO:6, or having a CDR1 represented by the amino acid sequence of SEQ ID NO:7, CDR2 represented by the amino acid sequence of SEQ ID NO:8, CDR3 represented by the amino acid sequence of SEQ ID NO:9, and the use is also proposed this vector for emergency prevention and prophylaxis of the disease caused by the SARS-CoV-2 virus.

EFFECT: inventions group provides for the creation of a recombinant viral vector that provides long-term protection against the SARS-CoV-2 virus.

7 cl, 8 dwg, 4 tbl, 9 ex